Agreed. The FDA trials are what have kept me here.
Post# of 72436
The progress in clinical FDA trials cannot be faked though. FDA trials + a real injection of cash (not the shoe string funding BS but $50M+) will jump start this company.
As for their interest in a $0.14 biotech with minimal funding options? Well, you can make 100% no matter where you start shorting from. They are vultures and believe we are barely breathing soon-to-be carrion if this deal doesn't come through. With the track record over the past year or two, betting against the EoP2 meeting doesn't seem like all that much of a long shot.
Let's see what they say. I'm all in holding more shares than I would like. Not a sign of confidence but more that most of the value is already gone so I might as well hold for a comeback. Buyer beware. Seller beware x2.
Go IPIX!
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)